NCT02639702 Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia Status RECRUITING Phase PHASE4
NCT02636842 A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE1
NCT02634684 Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia. Status COMPLETED Phase PHASE2
NCT02634671 Perception of Facial Emotions in Schizophrenia and 22q11 Deletion Syndrome Status COMPLETED Phase NA
NCT02634346 A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study) Status COMPLETED Phase PHASE3
NCT02634320 A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia Status COMPLETED Phase PHASE4
NCT02627716 Joint Crisis Plan Effectiveness in Preventing Relapses in Schizophrenia and Schizoaffective Disorder Status COMPLETED Phase NA
NCT02625103 The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring. Status COMPLETED Phase PHASE4
NCT02620267 Target Engagement of the Early Auditory Processing Network by Transcranial Direct Current Stimulation (tDCS) Status COMPLETED Phase NA
NCT02614586 Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia Status TERMINATED Phase PHASE1
NCT02600741 Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) Status COMPLETED Phase N/A
NCT02594696 Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness Status COMPLETED Phase NA
NCT02593734 Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana Status COMPLETED Phase PHASE4